EXPLORE!

Iron and Innate Immunity in Acute Kidney Injury: Promising Therapeutic Targets

  965 Views

Dr Swaminathan Sundararaman, USA    11 January 2018

Hepcidin-dependent dynamic relationship between renal and splenic iron content dictates responses to injury. Therapies targeting iron-hepcidin-ferroportin pathway holds promise in the treatment of diverse acute and chronic renal diseases. Hepcidin reduction and ferroptosis induction are promising novel strategies to target fibrosis and retard progression of CKD.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.